Residual lung abnormalities were consistent with elevated epithelial injury biomarkers, profibrotic signaling.
Microsoft Corporation reports a $625B backlog with 45% OpenAI risk; legacy moats and AI growth support the outlook. Check out why MSFT stock is a buy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results